DermTech, Inc. (DMTK) Financials
DMTK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 121.9 million | 64.8 million |
2023-09-30 | 137.9 million | 64.8 million |
2023-06-30 | 157.1 million | 69.0 million |
2023-03-31 | 177.1 million | 69.9 million |
DMTK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -12.5 million | 3.2 million |
2023-09-30 | -19.1 million | 3.2 million |
2023-06-30 | -23.5 million | 7.5 million |
2023-03-31 | -22.8 million | 4.7 million |
DMTK Net Income
No data available :(
DMTK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 55.9 million | - | 54.4 million |
2023-09-30 | 68.2 million | - | 55.2 million |
2023-06-30 | 86.2 million | - | 55.3 million |
2023-03-31 | 104.8 million | - | 55.6 million |
DMTK Shares Outstanding
DMTK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 163000 | 3.3 million | 8.4 million | 8.4 million |
2023-09-30 | 49000 | 3.6 million | 8.3 million | 8.1 million |
2023-06-30 | 259000 | 3.9 million | 15.2 million | 13.0 million |
2023-03-31 | 757000 | 4.4 million | 11.9 million | 15.4 million |
DMTK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 3.9 million | 3.5 million |
2023-09-30 | 3.9 million | 3.7 million |
2023-06-30 | 4.0 million | 4.0 million |
2023-03-31 | 3.5 million | 3.8 million |
DMTK
Price: $0.63
52 week price:
Earnings Per Share: -3.09 USD
P/E Ratio: -0.37
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 368700
Market Capitalization: 22.0 million